References
- GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:88–106.
- GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:939–953.
- Parkinson’s Foundation. Statistics 2020. [cited 2021 Feb 1]. Available from: http://www.parkinson.org/Understanding-Parkinsons/Causes-and-Statistics/Statistics
- Dorsey ER, Sherer T, Okun MS, et al. The emerging evidence of the Parkinson pandemic. J Parkinsons Dis. 2018;8:S3–S8.
- Marras C, Beck JC, Bower JH, et al. Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis. 2018;4:21.
- He S, Zhong S, Liu G, et al. Alpha-synuclein: the interplay of pathology, neuroinflammation, and environmental factors in Parkinson’s disease. Neurodegener Dis. 2020;20:55–64.
- Cotzias GC, Papavasiliou PS, Gellene R. Modification of Parkinsonism—chronic treatment with L-dopa. N Engl J Med. 1969;280:337–345.
- Tarakad A, Jankovic J. Diagnosis and management of Parkinson’s disease. Semin Neurol. 2017;37:118–126.
- Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323:548–560.
- Chou KL, Stacy M, Simuni T, et al. The spectrum of "off" in Parkinson’s disease: What have we learned over 40 years? Parkinsonism Relat Disord. 2018;51:9–16.
- Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord. 2001;16:448–458.
- Thanvi BR, Lo TC. Long term motor complications of levodopa: clinical features, mechanisms, and management strategies. Postgrad Med J. 2004;80:452–458.
- The Michael J. Fox Foundation for Parkinson’s Research. Capturing and elevating the patient voice. 2014 [cited 2020 Oct 13]. Available from: https://www.michaeljfox.org/news/capturing-and-elevating-patient-voice
- Yang W, Hamilton JL, Kopil C, et al. Current and projected future economic burden of Parkinson’s disease in the U.S. NPJ Parkinsons Dis. 2020;6:15.
- Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understand. Curr Med Res Opin. 2008;24:3063–3072.
- Huber PJ. The behavior of maximum likelihood estimates under nonstandard conditions. In: Vol. 1 of Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley (CA): University of California Press; 1967. p. 221–233.
- American Academy of Neurology (AAN). Medicare Physician Fee Schedule 2018. 2018 [cited 2018 Aug 16]. Available from: https://www.aan.com/siteassets/home-page/tools-and-resources/practicing-neurologist–administrators/billing-and-coding/medicare-fee-for-service/18medicarevalues_tr.pdf
- Centers for Disease Control and Prevention (CDC). National Ambulatory Medical Care Survey: 2015 State and National Summary Tables 2015. 2015 [cited 2018 Aug 16]. Available from: https://www.cms.gov/apps/physician-fee-schedule/search/search-results.aspx?Y=0&T=0&HT=2&CT=0&H1=99201&H2=99215&M=5
- Centers for Medicare & Medicaid Services (CMS). Physician Fee Schedule Search 2018. Available from: https://www.cms.gov/apps/physician-fee-schedule/search/search-results.aspx?Y=0&T=0&HT=2&CT=0&H1=99201&H2=99215&M=5
- Agency for Healthcare Research and Quality (AHRQ). HCUPnet – Healthcare Cost and Utilization Project 2015. [cited 2018 Aug 16]. Available from: https://hcupnet.ahrq.gov/#query/eyJBTkFMWVNJU19UWVBFIjpbIkFUX00iXSwiT1VUQ09NRV9NRUFTVVJFUyI6WyJPTV9OVU1CRVIiLCJPTV9SQVRFIiwiT01fTG9TIiwiT01fSENIIiwiT01fSENPIl0sIllFQVJTIjpbIllSXzIwMTUiXSwiUFJJTkNJUExFX09SX0FMTCI6WyJQQV9QUklOQ0lQTEUiXSwiQ0FURUdPUklaQVRJT05fVFlQRSI6WyJDVF9DQ1NEIl0sIkNUX0NDU0QiOlsiNDg1OCJdLCJEQVRBU0VUX1NPVVJDRSI6WyJEU19OSVMiXX0=
- StataCorp. Stata Statistical Software: Release 16. College Station (TX): StataCorp LLC; 2019.
- Ouma S, Fukae J, Fujioka S, et al. The risk factors for the wearing-off phenomenon in Parkinson’s disease in Japan: a cross-sectional, multicenter study. Intern Med. 2017;56:1961–1966.
- Sun B, Wang T, Li N, et al. Analysis of motor complication and relative factors in a cohort of Chinese patients with Parkinson’s disease. Parkinsons Dis. 2020;2020:8692509.
- Wan Y, Yuan C, Hou X, et al. Wearing-off identification in Parkinson’s disease: the shapd-woq study. Front Neurol. 2020;11:116.
- Kostic V, Przedborski S, Flaster E, et al. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson’s disease. Neurology. 1991;41:202–205.
- Kumar H, Ansari S, Kumar V, et al. Severity of caregiver stress in relation to severity of disease in persons with Parkinson’s. Cureus. 2019;11:e4358.
- Hassan A, Wu SS, Schmidt P, et al.; on behalf of the NPF-QII Investigators. High rates and the risk factors for emergency room visits and hospitalization in Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:949–954.
- Shahgholi L, De Jesus S, Wu SS, et al. Hospitalization and rehospitalization in Parkinson disease patients: data from the National Parkinson Foundation Centers of Excellence. PLoS One. 2017;12:e0180425.
- Bhattacharya PT, Hameed AMA, Bhattacharya ST, et al. Risk factors for 30-day readmission in adults hospitalized for pulmonary hypertension. Pulm Circ. 2020;10:2045894020966889.
- Trumbo H, Kaluza K, Numan S, et al. Frequency and associated costs of anaphylaxis- and hypersensitivity-related adverse events for intravenous iron products in the USA: an analysis using the US Food and Drug Administration Adverse Event Reporting System. Drug Saf. 2021;44:107–119.
- Zilberberg MD, Harrington R, Spalding JR, et al. Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004-2013. BMC Public Health. 2019;19:591.
- Dodel RC, Berger K, Oertel WH. Health-related quality of life and healthcare utilisation in patients with Parkinson’s disease: impact of motor fluctuations and dyskinesias. Pharmacoeconomics. 2001;19:1013–1038.
- Khandker RK, Ritchie CW, Black CM, et al. Multi-national, cross-sectional survey of healthcare resource utilization in patients with all stages of cognitive impairment, analyzed by disease severity, country, and geographical region. J Alzheimers Dis. 2020;75:1141–1152.
- Nalamachu S, Robinson RL, Viktrup L, et al. Pain severity and healthcare resource utilization in patients with osteoarthritis in the United States. Postgrad Med. 2021;133:10–19.
- Tang DH, Colayco D, Piercy J, et al. Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity. BMC Neurol. 2014;14:74.